William P. Forbes - 11 Feb 2022 Form 4/A - Amendment Insider Report for Trevi Therapeutics, Inc. (TRVI)

Reporting relationship: Chief Development Officer
Issuer ticker: TRVI
Reported as of: 11 Feb 2022
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 01 Jul 2022, 16:43:43 UTC
Original report date: 15 Feb 2022
Next SEC filing: 07 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Christopher Galletta, attorney-in-fact

Key filing fact

William P. Forbes filed Form 4/A - Amendment for Trevi Therapeutics, Inc. (TRVI) on 01 Jul 2022.

Key facts

This page summarizes William P. Forbes's Form 4/A - Amendment filing for Trevi Therapeutics, Inc. (TRVI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2022, 16:43.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRVI transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +137,500
Change %
Price: $0.000000
Shares after: 137,500
Date: 11 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 137,500
Exercise price: $0.5110
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option was granted on February 11, 2022. The 137,500 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 11, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.

Footnote F2

This amendment to the Form 4 originally filed for the reporting person on February 15, 2022 is being filed solely to attach the power of attorney exhibit that was inadvertently excluded from the original filing.

SEC remarks

Exhibit Index: 24 Power of Attorney